Yaben Química planeja uma emissão de ações para captar até 1,01 bilhão de yuans para financiar fluxo adicional, tendo apresentado prejuízos nos últimos 3 anos

China Economic Net Beijing, April 7th — Yabao Chemistry (300261.SZ) disclosed on the evening of the 2nd that in 2026 it plans to issue A-shares to specific targets. The recipients of this issuance include no more than 35 specific investors (including one of the company’s actual controllers, Cai Tong), such as securities investment fund management companies, securities firms, trust companies, financial companies, asset management companies, insurance institutional investors, qualified foreign institutional investors, other domestic legal person investors, individuals, or other qualified investors, all within the scope of Chinese regulations. Securities investment fund management companies, securities firms, wealth management companies, insurance companies, qualified foreign institutional investors, and Renminbi qualified foreign institutional investors subscribing with more than two products managed by them will be regarded as a single issuance target. Trust companies participating as issuance targets can only subscribe with their own funds. Cai Tong intends to subscribe with no less than 30 million yuan for this issuance, while other stocks will be subscribed by other issuance targets. All issuance targets will subscribe to the stocks issued in this round in cash.

The pricing date for this issuance to specific targets is the first day of the issuance period, and the issuance will be conducted via bidding. The issuance price shall not be less than 80% of the average trading price of the company’s shares over the 20 trading days prior to the pricing date.

The type of shares issued to specific targets in this round is domestic listed RMB ordinary shares (A-shares), with a par value of 1.00 yuan per share. These shares will be applied for listing and trading on the ChiNext Board of the Shenzhen Stock Exchange. The number of shares issued is calculated by dividing the total amount of funds raised by the issuance price, and shall not exceed 30% of the company’s total share capital before this issuance, i.e., no more than 288,992,841 shares (including this number).

The total funds raised from this issuance to specific targets will not exceed 1,005 million yuan (including this amount). After deducting issuance costs, the funds will be used for the “Annual Production of 700 Tons of High-end Pesticide Intermediates Project,” “Pilot Project of 35 Tons of High-end Pharmaceutical Intermediates,” “New Construction of 2019 Tons Raw Material Drugs and Intermediates (Phase I),” “New Construction of 140 Tons of Pharmaceutical Raw Material Drugs,” “New Construction of 50 Tons of Releglin and 2 Tons of SERD Inhibitors,” “R&D Center Construction Project,” and “Supplementary Working Capital.”

As of the announcement date of the plan, Cai Tong is the company’s chairman, general manager, and one of the actual controllers, and is a related party of the company. Therefore, this issuance constitutes a related-party transaction.

As of the announcement date, the company’s total share capital is 963,309,471 shares. On December 5, 2025, the company issued an announcement titled “Yabao Chemistry Co., Ltd. on the Donation of Shares by the Actual Controller and Changes in Shareholding Ratio Reaching Multiples of 1%,” stating that Cai Tong, one of the company’s actual controllers, signed the “Fudan Entrepreneur Stock Fund Donation Agreement” on December 3, 2025, donating 1.36M shares of the company’s stock to the Shanghai Fudan University Education Development Foundation free of charge, to establish the “Fudan Entrepreneur Stock Fund.” As of the announcement date, the donation agreement has not yet been fulfilled. Cai Tong and Wang Xinyao directly and indirectly control 36.03% of the company’s shares. After the completion of the donation, Cai Tong and Wang Xinyao will directly and indirectly control 35.89% of the company’s shares. After this issuance, the company’s total share capital will increase from 963,309,471 shares to no more than 1,252,302,312 shares. Cai Tong and Wang Xinyao remain the company’s actual controllers. Therefore, this issuance to specific targets will not lead to a change in the company’s actual control. Cai Tong and Wang Xinyao are of Hong Kong nationality.

According to the company’s 2025 performance forecast, in 2025, the net profit attributable to shareholders of the listed company is expected to lose between 140 million and 160 million yuan, a decrease of 37.91% to 45.67% compared to the same period last year; net profit after deducting non-recurring gains and losses is expected to lose between 128 million and 148 million yuan, a decrease of 42.69% to 50.43% compared to the same period last year.

In 2024, the company achieved operating revenue of 1.36M yuan, a year-on-year decrease of 6.00%; net profit attributable to shareholders of the listed company was -258 million yuan, compared to -82.2938 million yuan in 2023; net profit after deducting non-recurring gains and losses was -258 million yuan, compared to -105 million yuan in 2023; net cash flow from operating activities was 201 million yuan.

(Editor: Sun Chenwei)